The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
Ε. Kenneth Weir(University of Minnesota), Margaret Wu(National Institutes of Health), Stuart Rich(University of Chicago Medical Center), Edward H. Bergofsky(National Heart Lung and Blood Institute), Roberta M. Goldring(New York University), Katherine M. Detre(National Heart Lung and Blood Institute), C. Gregory Elliott(National Institutes of Health), Lynne Reid(Civil Service College), Janet T. Kernis(National Heart Lung and Blood Institute), Stephen M. Ayres(National Heart Lung and Blood Institute), Spencer K. Koerner, George W. Williams(Cleveland Clinic), Paul S. Levy, Alfred P. Fishman(National Institutes of Health), Bruce H. Brundage(National Heart Lung and Blood Institute), Bertron Μ. Groves(National Institutes of Health), Carol E. Vreim(National Institutes of Health), Giuseppe G. Pietra(National Heart Lung and Blood Institute), Lewis J. Rubin(University of California San Diego)
Cited by 188
Related Papers
Survival in Patients with Primary Pulmonary Hypertension
|Annals of Internal Medicine|1991|3.5k
The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education
|Annals of Neurology|1990|1.1k
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2003|809
Pathologic assessment of vasculopathies in pulmonary hypertension
|Journal of the American College of Cardiology|2004|713
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
|Journal of the American College of Cardiology|2006|612